• <rp id="mz6wu"><meter id="mz6wu"></meter></rp><rp id="mz6wu"></rp>
  • <ruby id="mz6wu"><optgroup id="mz6wu"></optgroup></ruby><rt id="mz6wu"><meter id="mz6wu"></meter></rt>

    <cite id="mz6wu"><form id="mz6wu"></form></cite><video id="mz6wu"><menuitem id="mz6wu"><option id="mz6wu"></option></menuitem></video>
    <source id="mz6wu"><nav id="mz6wu"></nav></source>
  • <tt id="mz6wu"></tt>
    <tt id="mz6wu"><noscript id="mz6wu"><samp id="mz6wu"></samp></noscript></tt><tt id="mz6wu"><noscript id="mz6wu"><label id="mz6wu"></label></noscript></tt>
  • Image by Solera
    January 30, 2018 | By Solera

    SVR For HCV With No Advanced Liver Disease Greatly Reduces Mortality Risk

    A study in the journal Hepatology found that patients diagnosed with hepatitis C who did not have advanced liver disease and attained sustained virologic response after treatment with direct-acting antiviral therapy had a lower mortality risk compared with untreated patients and patients who received DAAs but did not achieve SVR. The study analyzed data from 40,664 Department of Veterans Affairs patients with HCV genotype 1, 2 or 3.

    Click Here to view the original article at Specialty Pharmacy Times

    A smaller focus to make a much larger impact. Our goal is to deliver on every promise we make

    Our Mission

    Learn More
    182tv